Report #2884334

Received Feb 4, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: Feb 2, 2026
Onset: Feb 1, 2026
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Injection site pruritus

Symptom narrative

I am itching on the site; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site itching in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 02-FEB-2026, the patient received Shingrix. In FEB-2026, an unknown time after receiving Shingrix, the patient experienced injection site itching (Verbatim: I am itching on the site). The outcome of the injection site itching was not reported. It was unknown if the reporter considered the injection site itching to be related to Shingrix. It was unknown if the company considered the injection site itching to be related to Shingrix. Additional Information: GSK Receipt Date: 03-FEB-2026 The patient got the shingles shot yesterday and had itching on the site, so patient asked was that normal. The batch number was not provided and a request for this information has been made.